Ascoril Expectorant syrup 200ml — Made in Poland — Free Delivery

Ascoril expectorant is a combined preparation with bronchodilating, mucolytic and expectorant effects. Due to the rational combination of salbutamol, bromhexine hydrochloride, guaifenesin and menthol, it effectively and quickly reduces the severity of functional disorders of the respiratory system.

Salbutamol is a selective β2-adrenergic receptor agonist that effectively and for a long time dilates the bronchi. In therapeutic doses, it does not cause cardiac stimulation.

Bromhexine hydrochloride reduces the viscosity of sputum and promotes its evacuation from the bronchi.

Guaifenesin promotes expectoration and excretion of bronchial secretions. Menthol reduces the severity of irritation and inflammation of the mucous membrane of the respiratory tract.

Diseases of the respiratory tract, accompanied by the formation of a viscous hard-to-separate secretion - tracheobronchitis, chronic obstructive bronchitis, BA, pulmonary emphysema, pulmonary tuberculosis, pneumonia.

Adults and children aged 12 years and older - 10 ml (2 teaspoons) of syrup 3 times a day, children aged 6-12 years - 5-10 ml (1-2 teaspoons) of syrup 3 times a day, 2 –6 years - 5 ml (1 teaspoon) of syrup 3 times a day. the duration of treatment is determined individually.

Hypersensitivity to salbutamol and other sympathomimetics, bromhexine, guaifenesin, menthol or other components of the preparation, age up to 2 years.

The most common side effects associated with the use of salbutamol. they do not differ from those for other agonists of β2-adrenergic receptors and include muscle tremor (mainly hands), painful muscle spasms. sometimes moderate tachycardia, anxiety, headache, and peripheral vasodilation may develop. in patients sensitive to the action of β2-adrenergic agonists, against the background of a decrease in blood pressure, a compensatory increase in heart rate may develop. sometimes when using ascoril expectorant, disorders of the digestive tract (nausea, vomiting, diarrhea, abdominal pain) may develop, which are associated with the effects of guaifenesin, bromhexine hydrochloride and menthol.

Some patients may develop a transient increase in the activity of aminotransferases in the blood, caused by bromhexine.

It is prescribed with caution for hyperthyroidism, diabetes mellitus, diseases of the cardiovascular system (ischemic heart disease, ag, arrhythmia) and peptic ulcer of the stomach or duodenum.

The safety of using the preparation during pregnancy or lactation does not have a sufficient amount of documentary evidence, therefore, when prescribing the preparation, these categories of patients should carefully weigh the benefits obtained when using the preparation and the potential risk to the fetus or infant. It is recommended to stop breastfeeding while using the preparation.

During the period of taking the preparation, it is better to refrain from driving vehicles and other activities that require precise coordination, speed of reaction and concentration of attention.

Hypokalemia, which develops as a result of the use of preparations containing salbutamol, may increase with the combined administration of diuretics. as a result of this, the risk of developing arrhythmias increases when cardiac glycosides are used against the background of such treatment.

The severity of the effects of salbutamol can be reduced with the simultaneous use of β-adrenergic receptor blockers, especially nonselective (propranolol), and may also increase with the simultaneous use of xanthines (theophylline).

Overdose may result in agitation, confusion, and respiratory depression. treatment is symptomatic.

In a dry, dark place at temperatures up to 25 ° C.